Jonathan W. Painter
Analyst · Rudy Hokanson, Barrington
Thanks, Tom. Hello, everyone. It's my pleasure to brief you on our first quarter results, as well as update you on our outlook for 2014.
Overall, we had a great quarter with record bookings and adjusted EBITDA. I'll begin today's business review of the financial highlights of the quarter. We finished the quarter with revenue of $93 million, which was up 23% compared to the first quarter of 2013. Gross margins remains strong at 45%. Operating income was $7.6 million, up 3% compared to Q1 of last year. More importantly, our adjusted EBITDA was a new record at $12.7 million or nearly 14% of sales, up 36% compared to Q1 of last year. Our GAAP diluted earnings per share was $0.45 in the first quarter, including $0.02 of restructuring costs and $0.13 of expense related to acquired profit in inventory and backlog associated with the businesses we acquired last year. Without question, the highlight of the quarter was our record bookings, which increased 27% over Q1 of last year to $115 million.
Turning to our revenue performance. You can see that all of our product lines are up for the first quarter. The most significant contributor to our year-over-year revenue growth was our acquisitions, which contributed $19 million to Q1 revenue. Excluding acquisitions, our Q1 revenues were down slightly compared to the same period last year. I'll discuss this in more detail when I cover our business activity in the specific regions of the world.
As I noted, the highlight of the quarter was our record bookings. I also noted on our last call that we anticipated a significant step-up in bookings in the first half of 2014, and I can say they're coming in about as we expected. Our bookings of $115 million in Q1 were up 27% compared to Q1 of last year with acquisitions contributing $16 million. Excluding the impact from acquisitions, our bookings were still up 9% compared to the same period last year, which was an excellent start to the year. The strong bookings performance was broadly based with all of our major product lines increasing 20% or more. It was also a solid booking quarter for both capital and spare parts. Very strong capital bookings in our Doctoring, Cleaning & Filtration and Stock-Prep product lines in North America contributed to a 38% increase in global capital bookings in Q1 compared to Q1 of last year. I should also note that our Wood Processing Systems product line is off to an excellent start in Q2 with nearly $7 million worth of major orders booked in April.
Overall, I'm very encouraged, not only by our booking performance in Q2, but also by the continued activity level we are seeing in Q2. The bookings and revenue trend charts on Slide 8 shows our quarterly revenue, which is the red line; and our bookings, which are the blue bars. Although Q1 revenue was down slightly from Q4, the record bookings in Q1 will boost revenue in the coming quarters.
Finally, as I mentioned, bookings were up nearly 37% sequentially to a record $115 million. Our revenue for Parts and Consumables was also a record $61 million for the first quarter and made up 65% of our revenues. The companies we acquired last year had very strong Parts and Consumables business, and this has led to our record results. Revenue was up 3% sequentially and 19% over Q1 of last year, with particularly strong performance in our Fluid-Handling product line. We also had record Parts and Consumables bookings, which were up 20% over Q1 of last year and 18% sequentially.
I'd now like to take the next few minutes to provide a brief review of our business activities in each of the major geographic regions of the world. Let me start with North America. North America was definitely the star of Q1 with the strongest regional performance in both bookings and revenues. Our revenues in North America were up 38% compared to the first quarter of 2013 to $54 million, and up 32% sequentially. Most of our major product lines had substantial increases in revenue.
Overall, I can say we're seeing a very good environment for capital investment, particularly in the U.S. There are several rebuilds going on in this year, as well as conversions from newsprint to container board such as PCA's conversion of its newly acquired mill and driller Louisiana. Bookings in North America in Q1 were $70 million, up 61% compared to the same period last year and 60% sequentially. All of our major product lines have significant increases in bookings. The addition of Carmanah, which is based in North America, it was also a major contributor to our booking performance. I should note that Q1 included a large Stock-Prep capital order for a customer in Mexico valued at more than $11 million, that I mentioned in our Q4 call in February.
We continue to see a very healthy level of a project activity in North America, including several large chemical pulping projects in the U.S. For the last several years, we focused on developing product offerings for virgin fiber. The fiber cost for virgin mills in the U.S. Southeast are the lowest in the world, and this low cost advantage is driving increased capital investments, which in turn, is providing opportunity for our Chemical Pulping business.
The market in Europe is not as strong as North America, but we are seeing growing signs of improvement. Our Q1 revenues in Europe were $20 million, up 17% over Q1 last year, but were down 24% sequentially from a relatively strong Q4. Q1 bookings of $25 million were down 9% compared to a strong Q1 of last year, but were up 27% sequentially.
2014 is off to a good start in Europe. So far this year, we've received orders for 2 Stock-Prep systems upgrades for customers in Turkey with a combined value of more than $3 million, and an order for a dryer system section rebuild for a customer in Russia. Needless to say, we are cautious about the situation in Russia. At this point, however, our exposure is fairly limited with only $1.7 million of our backlog from customers in Russia.
Next, let's take a look at China. The economy in China has remained relatively weak and investments in new capacity seem to be shifting to investments in improved efficiency. While the focus on efficiency improvements can benefit from Kadant products, the sluggish economic environment has suppressed our revenue and bookings in Q1.
Our Q1 revenues in China were $7 million, down 40% compared to Q1 of last year and down 46% sequentially. This decline in revenue was found in our all of our major product lines, but particularly, in our Stock-Prep product line. Our bookings in China were down 22% in Q1 to $9 million compared to Q1 of last year, but up 5% sequentially due to higher capital orders in our stock -- of Stock-Prep improvement.
I can say despite the weak market environment, we are seeing some project activity in China, including some large Stock-Prep's system projects. In fact, in April, we received an order for $3.8 million for an approach flow on OCC system for a recycle linerboard customer. Although the pulping paper industry in China is somewhat soft, the market for oriented strand board, or OSB, which is a new product for the China market is quite promising. Potential applications for OSB in China include crating material and container bed liners used in shipping, as well as forms for pouring concrete foundation and subflooring for construction. Since OSB is more cost effective to produce than plywood and does not require large trees, which are scarce in China, it's ideal for this market. There were 2 strand orders in China so far this year, and I'm pleased to report that we secured both of them in April for a combined value of more than $4 million.
These installations will provide valuable references in this growing region.
Turning to South America in Slide 14. You can see the first quarter of 2014 was significantly stronger than the first quarter of 2013 due to the acquisition of CBTI. Revenues in South America were $7 million in Q1, up 64% compared to the same period last year, or down 31% sequentially. Bookings in Q1 more than doubled to $6 million compared to the same period last year, although they were down 11% sequentially.
In general, the market in South America and specifically, Brazil, has been impacted by the overall weakness of the economy. There is, however, a small but growing middle-class, it is expected to continue to drive demand for container board and tissue products in the coming years.
Let me close my remarks with a few comments on our guidance for Q2 and the full year of 2014. Our strong bookings in Q1 and expected strong bookings in Q2 put us in a good position for 2014. For the second quarter, we expect to generate $0.66 to $0.68 of GAAP diluted earnings per share and revenues of $104 million to $106 million, which includes $0.04 for amortization of acquired profit in inventory and backlog. For the full year, we're maintaining our GAAP diluted earnings per share guidance of $2.60 to $2.70, but increasing our revenue guidance to $410 million to $420 million, up from our previous guidance of $405 million to $415 million.
You might ask why, given the Q1 EPS strong bookings and the increase in revenue guidance, we're not also increasing our earnings per share guidance for the year. In short, the answer is taxes. We're now anticipating a higher percentage of our income from higher tax jurisdictions such as the U.S., and this has led us to increase our forecasted tax rate from 32% to 34%. This increase is adversely affected our expected earnings per share by $0.11 for the year.
I'll now pass the call over to Tom for additional details on our financial performance in Q1. Tom?